Nanoparticle-Mediated Delivery Market Size, Trends, Share, Growth, and Opportunity Forecast, 2024 - 2031 Global Industry Analysis By Product Type (Nanoparticle-based Drug Delivery Systems, Nanoparticle-based Imaging Agents), By Application (Oncology, Neurology, Cardiovascular Disorders, Infectious Diseases, Others), By End User (Hospitals & Clinics, Research Institutes, Pharmaceutical & Biotechnology Companies), and By Geography (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

By Product Type

·         Nanoparticle-based Drug Delivery Systems

·         Nanoparticle-based Imaging Agents

By Application

·         Oncology

·         Neurology

·         Cardiovascular Disorders

·         Infectious Diseases

·         Others

By End User

·         Hospitals & Clinics

·         Research Institutes

·         Pharmaceutical & Biotechnology Companies

By Geography

·         North America

·         Europe

·         Asia Pacific

·         South America

·         Middle East & Africa

Companies Profiled

·         Pfizer Inc.

·         Merck & Co., Inc.

·         Novartis AG

·         Johnson & Johnson Services, Inc.

·         Roche Holding AG

·         Sanofi S.A.

·         Amgen Inc.

·         AbbVie Inc.

·         Gilead Sciences, Inc.

·         AstraZeneca PLC

·         Bristol Myers Squibb Company

·         Eli Lilly and Company

·         GlaxoSmithKline PLC

·         Takeda Pharmaceutical Company Limited

·         Biogen Inc.